The Biliary Epigenetics and Regenerative Medicine Lab of Robert C. Huebert, M.D., includes research programs and a biobank containing stem cells from patients with liver disease.

Dr. Lundstrom's team collaborates and shares support staff with the Bioelectronics Neurophysiology and Engineering Laboratory of Gregory A. Worrell, M.D., Ph.D. Benjamin H. Brinkmann, Ph.D.

While our emphasis is on supporting the research themes, the disease focus groups set the stage for translating basic science discoveries to human disease. Organizing center faculty members into ...

Describes the nature of a clinical study. Types include: Observational study — observes people and measures outcomes without affecting results. Interventional study (clinical trial) — studies new ...

The Mayo Clinic Study of Aging and the Alzheimer's Disease Research Center yield a rich record of clinical, biomarker and neuropathological data. These data are available to qualified academic and ...

Mayo Clinic researchers Robert C. Huebert, M.D., and Jorge Rakela, M.D., a hepatologist at Mayo Clinic's campus in Phoenix, Arizona, discuss the amazing regenerative properties of the liver, the need ...

The Aspirin-Exacerbated Respiratory Disease Laboratory of Elina Jerschow, M.D., M.S., at Mayo Clinic is advancing understanding of AERD and related conditions.

Dr. Huebert has received funding for research in his Biliary Epigenetics and Regenerative Medicine Laboratory from a variety of organizations, including the National Institute of Diabetes and ...

The Epigenomics and Spatial Biology Core of the Center for Cell Signaling in Gastroenterology provides novel epigenomics and spatial biology technologies and expertise to support faculty research ...

Mayo Clinic Research Innovation provides Mayo Clinic's innovators with the knowledge and resources they need, reducing barriers to innovation.

Mayo Clinic’s strategy in regenerative biotherapeutics emphasizes an enhanced capability for biomanufacturing, with technology platforms supporting the development of new therapeutics known as ...